Picture of BioMaxima SA logo

BMX BioMaxima SA Cashflow Statement

0.000.00%
pl flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapContrarian

Annual cashflow statement for BioMaxima SA, fiscal year end - December 31st, PLN millions except per share, conversion factor applied.

2017
December 31st
2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
PAS
PAS
PAS
PAS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line0.806-0.482-0.0147.3612.8
Depreciation
Non-Cash Items0.0010.05-0.1010.160.023
Unusual Items
Other Non-Cash Items
Changes in Working Capital-0.7671.153.36-5.44-14.6
Change in Accounts Receivable
Change in Inventories
Change in Accounts Payable
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities1.842.124.933.97-0.132
Capital Expenditures-2.17-17.4-1.64-1.88-4.48
Purchase of Fixed Assets
Other Investing Cash Flow Items0.1310.2640.0390.2311.11
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-2.04-17.2-1.6-1.65-3.37
Financing Cash Flow Items-0.1143.990.090.16-0.169
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities0.3914.8-3.851.482.11
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash0.193-0.286-0.5183.8-1.39

Or unlock with your email

Or unlock with your email